Price
Financials
Standalone, Rs crore| Dec 2011 | Mar 2012 | Jun 2012 | Sep 2012 | Dec 2012 | Mar 2013 | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 138 | 153 | 168 | 157 | 171 | 182 | 167 | 171 | 161 | 180 | 193 | 208 |
| Expenses | 110 | 102 | 119 | 120 | 140 | 138 | 142 | 152 | 141 | 141 | 155 | 161 |
| Operating Profit | 28 | 51 | 49 | 37 | 31 | 44 | 25 | 19 | 20 | 38 | 38 | 47 |
| OPM % | 20% | 33% | 29% | 24% | 18% | 24% | 15% | 11% | 12% | 21% | 20% | 23% |
| Other Income | 8 | 13 | 10 | 9 | 8 | 9 | 9 | 10 | 8 | 8 | 6 | 5 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 34 | 63 | 58 | 45 | 38 | 52 | 34 | 28 | 27 | 45 | 43 | 51 |
| Tax % | 28% | 31% | 33% | 33% | 33% | 32% | 35% | 35% | 35% | 34% | 34% | 35% |
| Net Profit | 25 | 44 | 39 | 30 | 26 | 35 | 22 | 18 | 17 | 30 | 28 | 34 |
| EPS in Rs | 10.84 | 19.23 | 17.15 | 13.33 | 11.33 | 15.50 | 9.77 | 8.10 | 7.69 | 13.17 | 12.54 | 14.78 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 8m | Mar 2011 16m | Mar 2012 | Mar 2013 | Mar 2014 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 286 | 285 | 329 | 382 | 286 | 640 | 588 | 678 | 679 | 742 |
| Expenses | 213 | 186 | 223 | 253 | 207 | 412 | 415 | 516 | 576 | 598 |
| Operating Profit | 73 | 99 | 106 | 129 | 79 | 228 | 173 | 162 | 103 | 143 |
| OPM % | 25% | 35% | 32% | 34% | 28% | 36% | 29% | 24% | 15% | 19% |
| Other Income | 18 | 19 | 19 | 21 | 10 | 18 | 39 | 35 | 34 | 26 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 9 | 6 | 3 | 3 | 3 |
| Profit before tax | 84 | 111 | 118 | 142 | 82 | 236 | 205 | 193 | 134 | 166 |
| Tax % | 19% | 17% | 31% | 30% | 28% | 30% | 29% | 33% | 34% | |
| Net Profit | 68 | 92 | 81 | 100 | 59 | 165 | 145 | 130 | 88 | 109 |
| EPS in Rs | 29.83 | 40.69 | 35.89 | 43.91 | 25.99 | 72.81 | 63.74 | 57.30 | 38.73 | 48.18 |
| Dividend Payout % | 84% | 74% | 84% | 74% | 77% | 30% | 28% | 30% | 375% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 12% | 2% | 7% | ||
| Compounded Profit Growth | % | -3% | -19% | 8% | ||
| Stock Price CAGR | % | % | % | % | ||
| Return on Equity | % | 30% | 26% | 21% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 |
| Reserves | 223 | 234 | 236 | 249 | 255 | 362 | 459 | 544 | 247 |
| Borrowings | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Other Liabilities | 106 | 122 | 132 | 158 | 124 | 112 | 165 | 223 | 232 |
| Total Liabilities | 354 | 381 | 393 | 432 | 404 | 499 | 649 | 792 | 504 |
| Fixed Assets | 47 | 43 | 39 | 38 | 31 | 26 | 24 | 24 | 24 |
| CWIP | 0 | 1 | 3 | 1 | 2 | 2 | 2 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 306 | 336 | 351 | 393 | 371 | 472 | 624 | 768 | 479 |
| Total Assets | 354 | 381 | 393 | 432 | 404 | 499 | 649 | 792 | 504 |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 61 | 79 | 86 | 60 | 58 | 151 | 76 | 92 | 119 |
| Cash from Investing Activity | 11 | 14 | 13 | 14 | 10 | 12 | 31 | 32 | 29 |
| Cash from Financing Activity | -52 | -65 | -80 | -80 | -86 | -94 | -19 | -48 | -430 |
| Net Cash Flow | 20 | 28 | 18 | -6 | -18 | 69 | 89 | 76 | -282 |
| Free Cash Flow | 64 | 78 | 81 | 57 | 56 | 145 | 79 | 92 | 116 |
| CFO/OP | 88% | 99% | 110% | 83% | 93% | 94% | 81% | 103% | 163% |
| Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Nov 2009 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 25 | 25 | 25 | 23 | 25 | 19 | 34 | 24 | 27 |
| Inventory Days | 168 | 198 | 139 | 177 | 228 | 128 | 207 | 247 | 179 |
| Days Payable | 97 | 104 | 120 | 165 | 171 | 109 | 139 | 188 | 202 |
| Cash Conversion Cycle | 97 | 118 | 44 | 36 | 82 | 39 | 102 | 83 | 4 |
| Working Capital Days | 4 | -9 | -20 | 6 | 45 | 27 | 38 | 27 | 17 |
| ROCE % | 43% | 45% | 54% | 30% | 72% | 46% | 37% | 32% |
Fundamentals
Market Cap₹ Cr.
Current Price₹ 1,334
Book Value₹ 146
ROCE31.9 %
ROE21.0 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)7%
Compounded Profit Growth (TTM)8%
Standalone figures.
Valuation
Market capRs 3,031 Cr
Enterprise valueRs 2,594 Cr
P/E (TTM)27.71x
Price to book5.35x
Price to sales4.09x
EV / EBITDA15.23x
EV / EBIT15.50x
EV / sales3.50x
Price to cash flow32.83x
Earnings yield3.61%
Dividend yield1.27%
P/E, 3-year average13.82x
P/B, 3-year average4.30x
P/E, 5-year average15.82x
P/B, 5-year average4.47x
Profitability
Operating margin (excl. other income)23.86%
Operating margin (incl. other income)29.06%
EBITDA margin22.97%
Pre-tax margin22.43%
Net profit margin14.75%
Net margin, latest quarter16.14%
ROE24.80%
ROCE36.88%
ROA18.05%
ROE, 3-year average36.04%
ROCE, 3-year average51.71%
ROA, 3-year average26.61%
ROE, 5-year average33.44%
ROCE, 5-year average47.62%
ROA, 5-year average23.62%
ROIC (approx.)86.64%
Tax rate32.71%
Other income / net worth6.22%
Growth
Sales growth (latest year)15.30%
Profit growth (latest year)-10.11%
Sales CAGR, 3 years33.35%
Sales CAGR, 5 years15.56%
Profit CAGR, 3 years30.15%
Profit CAGR, 5 years9.80%
Sales growth QoQ7.89%
Profit growth QoQ17.92%
Sales growth YoY (latest quarter)21.36%
Profit growth YoY (latest quarter)82.59%
Per share
EPS (TTM)Rs 48.14
EPS (latest year)Rs 57.24
EPS (latest quarter)Rs 14.77
EPS, 3-year averageRs 64.56
EPS, 5-year averageRs 52.70
Book value per shareRs 249.47
Sales per shareRs 326.42
Cash flow per shareRs 40.63
Free cash flow per shareRs 51.06
Dividend per share (latest year)Rs 17.00
Dividend per share, 3-year averageRs 19.00
Dividend per share, 5-year averageRs 21.90
Dividends
Dividend payout29.69%
Dividend payout, 3-year average29.40%
Dividend payout, 5-year average47.86%
Efficiency
Asset turnover0.86x
Fixed asset turnover28.06x
Inventory turnover1.54x
Inventory days237 days
Debtor days24 days
Debtors turnover15.23x
Creditor days202 days
Cash conversion cycle4 days
Working capital days17 days
Leverage
Total debtRs 2 Cr
Cash and bankRs 439 Cr
Net debtRs -437 Cr
Debt to equity0.00x
Net debt / EBITDA-2.56x
Interest coverage159.40x
Owners' fund to total sources71.57%
Debt to assets0.32%
Cash flow
Cash from Operating Activity (latest year)Rs 92 Cr
Cash from Investing Activity (latest year)Rs 32 Cr
Cash from Financing Activity (latest year)Rs -48 Cr
Net Cash Flow (latest year)Rs 76 Cr
Free cash flow (latest year)Rs 116 Cr
FCFE (approx.: FCF + change in debt)Rs 116 Cr
Cash from ops / profit, 5 years0.80x
Sales to cash flow7.34x
Statement figures
Net sales (TTM)Rs 742 Cr
Net sales (latest year)Rs 678 Cr
Sales (latest quarter)Rs 208 Cr
Operating profit excl. other income (latest year)Rs 162 Cr
Operating profit (latest quarter)Rs 47 Cr
Other income (TTM)Rs 26 Cr
EBITDA (TTM)Rs 170 Cr
PBDT (TTM)Rs 169 Cr
Profit before tax (TTM)Rs 166 Cr
Tax (latest year)Rs 63 Cr
Net profit (TTM)Rs 109 Cr
Net profit (latest year)Rs 130 Cr
Net profit (latest quarter)Rs 34 Cr
Depreciation (TTM)Rs 3 Cr
Depreciation (latest quarter)Rs 1 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 284 Cr
Total expenditure (latest year)Rs 516 Cr
Total income (latest year)Rs 713 Cr
Share capitalRs 23 Cr
ReservesRs 544 Cr
Shareholders' fundsRs 567 Cr
Total assetsRs 792 Cr
Net blockRs 24 Cr
Capital work in progressRs 0 Cr
ReceivablesRs 44 Cr
InventoryRs 184 Cr
Other liabilitiesRs 223 Cr
Shares outstanding (crore)2.27
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | WYETH | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +7.7% | -2.8% | +10.5 pts |
| 1 month | +17.6% | -6.8% | +24.4 pts |
| 3 months | +35.9% | -7.6% | +43.5 pts |
| 6 months | +51.6% | +0.4% | +51.2 pts |
| 1 year | +40.5% | -9.9% | +50.4 pts |
| 2 years | +53.3% | -13.6% | +66.8 pts |
| 3 years | +43.6% | +14.2% | +29.4 pts |
| 5 years | +74.4% | +27.9% | +46.5 pts |
Red flags
F-score 4 of 8| look | Inventory outrunning sales Inventory grew 54% vs sales +15% in 2014 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Sep 2014Sales ₹208 Cr +21.6% vs Sep 2013.
Net profit ₹34 Cr +88.9%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2014-10-29 | Annual General Meeting | |
| 2013-12-05 | Interim Dividend - Rs 145/- Per Share | |
| 2013-08-28 | Annual General Meeting And Dividend Rs.17/- Per Share | |
| 2012-07-18 | Annual General Meeting And Dividend Rs.18/- Per Share (Bc Dates Revised) | |
| 2011-06-30 | Annual General Meeting And Dividend Rs.7/- Per Share | |
| 2011-01-20 | Interim Dividend-Rs.15/- Per Share | |
| 2010-04-06 | Agm/Div-Rs.20/- Per Share | |
| 2009-08-10 | Agm/Div-Rs.32.50 Pr Share | |
| 2008-08-22 | Agm/Dividend - 300% | |
| 2007-08-17 | Agm/Dividend-300% | |
| 2006-08-22 | Agm/Dividend-250% |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Wyeth Ltd(Merged)?
Wyeth Ltd(Merged) (WYETH) has a market capitalisation of Rs Cr. at the 2014-12-09 close.
What were Wyeth Ltd(Merged)'s latest quarterly results?
In the Sep 2014 quarter, Wyeth Ltd(Merged) sales was Rs 208 Cr (+21.6% vs Sep 2013) and net profit was Rs 34 Cr.